Cutler Group LP Takeda Pharmaceutical CO LTD Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$12.8 - $28.65 $34,560 - $77,355	-2,700 Reduced 96.43%	100 $0
Q2 2022 Aug 04, 2022	BUY	$13.12 - $15.03 $17,056 - $19,539	1,300 Added 86.67%	2,800 $0
Q4 2021 Jan 18, 2022	SELL	$13.17 - $16.4 $7,902 - $9,840	-600 Reduced 28.57%	1,500 $0
Q3 2021 Oct 26, 2021	BUY	$16.3 - $17.26 $3,260 - $3,452	200 Added 10.53%	2,100 $0
Q2 2021 Jul 19, 2021	BUY	$16.55 - $18.64 $31,445 - $35,416	1,900 New	1,900 $0
Q1 2021 Apr 26, 2021	SELL	$16.71 - $19.9 $147,048 - $175,120	-8,800 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$15.39 - $18.97 $15,390 - $18,970	-1,000 Reduced 10.2%	8,800 $28,000
Q1 2020 May 07, 2020	SELL	$13.02 - $20.31 $140,616 - $219,348	-10,800 Reduced 52.43%	9,800 $21,000
Q4 2019 Feb 06, 2020	BUY	$16.88 - $20.83 $3,376 - $4,166	200 Added 0.98%	20,600 $63,000
Q3 2019 Oct 28, 2019	SELL	$16.15 - $17.99 $14,534 - $16,190	-900 Reduced 4.23%	20,400 $41,000
Q2 2019 Aug 09, 2019	BUY	$16.58 - $20.49 $353,153 - $436,436	21,300 New	21,300 $52,000

335

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.